Stock GXGXU GX ACQU
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases GX ACQU Nasdaq

Equities

GXGXU

US36251A2069

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
GX Acquisition : Clinical pipeline includes multiple clinical stage programs including acute myeloid leukemia (AML) and glioblastoma multiforme (GBM), with a total of five clinical programs expected by 1H 2022 (Form 8-K)
PU
GX Acquisition : Submission of Matters to a Vote of Security Holders (Form 8-K)
PU
GX ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
GX Acquisition : Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine in the United States (Form 8-K)
PU
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
GX Acquisition : Celularity Announces Expansion of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Phase 1 Trial in Patients with Acute Myeloid Leukemia (Form 8-K)
PU
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
GX ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
GX ACQUISITION : 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
AQ
GX ACQUISITION CORP. : Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
GX Acquisition Corp. : Announces Shareholder Approval of Extension Proposal
PR
GX Acquisition : Announces Additional Contributions to Trust Account (Form 8-K)
PU
GX ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
GX Acquisition Corp. : Announces Additional Contributions to Trust Account
PR
GX Acquisition : Celularity to leverage Palantir’s next generation software and computational capabilities with their deep cellular data set to accelerate research and development activities
PU
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Palantir Technologies : Celularity Enters into Multi-Year Strategic Partnership with Palantir Technologies
AQ
GX ACQUISITION CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
GX Acquisition Corp. : Provides Information Regarding Extension of Deadline to Complete Celularity Business Combination
PR
GX ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GXGX Stock
  4. GXGXU Stock
  5. News GX ACQU
  6. Press Releases